Becton Dickinson & Co: Pay

Becton Dickinson & Co paid its 5 named executives $34.2M in total in FY2025 (Sep). CEO Thomas E. Polen was paid $17.1M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Thomas E. PolenChairman, Chief Executive Officer and President
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)
FY2021 (Sep)
5 years
Christopher J. DelOreficeExecutive Vice President and Chief Financial Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)
FY2021 (Sep)
5 years
Michael C. FeldExecutive Vice President, Chief Revenue Officer and President, Life Sciences Segment
FY2025 (Sep)
1 year
Michael D. GarrisonExecutive Vice President and President, Medical Essentials and BioPharma Systems Segments
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
3 years
Richard E. ByrdExecutive Vice President and President, Interventional Segment
FY2025 (Sep)
FY2024 (Sep)
2 years

CEO pay against the pay peers

In FY2025 (Sep), the median CEO pay of the 6 peers with pay on file was $22.5M. The CEO of Becton Dickinson & Co was paid $17.1M, 24% below the median.

  1. 1Thermo Fisher Scientific
  2. 2Abbott Laboratories
  3. 3Boston Scientific
  4. 4Stryker
  5. 5Becton Dickinson & Co
  6. 6Zimmer Biomet Holdings
  7. 7Agilent Technologies
  8. 8Baxter InternationalNot disclosed
  9. 9Danaher CorporationNot disclosed
  10. 10GE HealthCare TechnologiesNot disclosed
  11. 11MedtronicNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.